Biotech Values

[dewophile]

i think the ribavirin column is misleading
gild and roche both have a lead-in portion of therapy without rib in some arms, but all pts will ultimately recieve ribavirin. given the main MOA of ribavirin is to prevent relapse, any exposure to ribavirin prior to an SVR endpoint doesn't mean much in assessing if ribavirin can be dropped from the regimen altogether